Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.
About the role
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
What they're looking for
- Master's Degree in Biostatistics, Statistics, Computer Science or other relevant fields with at least 12 years of experience in providing statistical programming support in clinical trial setting
- Deep understanding about data standards with rich experience in understanding Pinnacle 21 validation report and creating Define XML packages to support regulatory filing
- Proficient in statistical computational software such as SAS, including complicated data steps, SAS macro languages, and commonly used analysis procedures (e.g., PROC Freq, PROC REPORT, PROC GLM, and PROC MIXED)
- Demonstrated capacity of collaboration with biostatisticians, Clinical Data Management and colleagues from other functions to deliver common goals
- Strong organizational and project management skills demonstrated interest in continued learning and growing
- Proven to work well on multiple projects in a fast-paced environment
More about this role
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...
Browse similar: Startup jobs · Remote jobs